-
Mashup Score: 0Auttx gets ALS Network grant to develop new treatments for ALS - 18 day(s) ago
Auttx has received a grant from the ALS Network to advance research on treatments for ALS that could restore normal RNA processing functions.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0Avicenna gets patent for ROCK inhibitor compounds for ALS, more - 20 day(s) ago
Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions. https://t.co/jLQWtT2iEX
-
-
Mashup Score: 4RNS60 aids mitochondria health, protects motor neurons in ALS mice - 1 month(s) ago
RNS60 is an experimental therapy designed to boost the formation of new mitochondria and restore energy production in nerve cells.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
Lucky rodents. RNS60 is an experimental therapy designed to boost the formation of new mitochondria and restore energy production in nerve cells. https://t.co/kHMTjgrPMM
-
-
Mashup Score: 0Mabylon receives funding to advance TDP-43 intrabodies for ALS - 2 month(s) ago
Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore TDP-43 in patients.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore TDP-43 in patients. https://t.co/sOWbiLhlXQ
-
-
Mashup Score: 7Clene submits new CNM-Au8 efficacy data head of FDA meeting - 2 month(s) ago
Clene submitted new data on CNM-Au8 to the FDA ahead of an upcoming meeting to discuss potential accelerated approval for the ALS therapy.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
Clene submitted new data on CNM-Au8 to the FDA ahead of an upcoming meeting to discuss potential accelerated approval for the ALS therapy. https://t.co/1hlJDsrDKa
-
-
Mashup Score: 3Bill targets research on environmental factors and ALS - 3 month(s) ago
Proposed U.S. legislation would advance research on the link between environmental factors and ALS and other neurodegenerative diseases.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
Can we please eliminate the expensive duplication of efforts between CDC and NIH??? https://t.co/rl7mXcCdd1
-
-
Mashup Score: 0Study from Norway links physical activity to lower ALS risk in men - 5 month(s) ago
Men who exercised more and were more fit were found to be at a lower risk of developing ALS in a Norwegian study.
Source: alsnewstoday.comCategories: General Medicine News, Partners & KOLsTweet-
Men who exercised more and were more fit were found to be at a lower risk of developing ALS in a Norwegian study. https://t.co/VW3jWD5XfM
-
-
Mashup Score: 3ProJenX wins $1M ALS Association grant to test progestin in... - 5 month(s) ago
ProJenX received a $1M ALS Association grant to support an early-stage clinical trial to begin testing prosetin in people with ALS.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
ProJenX received a $1M ALS Association grant to support an early-stage clinical trial to begin testing prosetin in people with ALS. https://t.co/4Gq7X0BwMY
-
-
Mashup Score: 1ETSU ALS clinic wins $75K grant to expand its free care services - 7 month(s) ago
The clinic at East Tennessee State University Health is the only one in the state to offer free multidisciplinary care to ALS patients.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
Does this mean that they're not charging payers for services? Free? ??? @alsnewstoday The clinic at East Tennessee State University Health is the only one in the state to offer free multidisciplinary care to ALS patients. https://t.co/ZgoDPBWsLl
-
-
Mashup Score: 3Gift supports Ball State University work into C9orf72-linked ALS - 9 month(s) ago
A Ball State University team was given $20,000 by the Todd Siebert Memorial Foundation to advance way of treating C9orf72-associated ALS.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
A Ball State University team was given $20,000 by the Todd Siebert Memorial Foundation to advance way of treating C9orf72-associated ALS. https://t.co/A9TOtbeBWJ
-
Auttx has received a grant from the ALS Network to advance research on treatments for ALS that could restore normal RNA processing functions. https://t.co/5clJaeUFxX